Detalles de la búsqueda
1.
Systematic assessment of the replicability and generalizability of preclinical findings: Impact of protocol harmonization across laboratory sites.
PLoS Biol
; 20(11): e3001886, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-36417471
2.
Imaging correlates of behavioral impairments: An experimental PET study in the rat pilocarpine epilepsy model.
Neurobiol Dis
; 118: 9-21, 2018 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-29933054
3.
Imaging biomarkers of behavioral impairments: A pilot micro-positron emission tomographic study in a rat electrical post-status epilepticus model.
Epilepsia
; 59(12): 2194-2205, 2018 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-30370531
4.
The Effects of Physiological and Methodological Determinants on 18F-FDG Mouse Brain Imaging Exemplified in a Double Transgenic Alzheimer Model.
Mol Imaging
; 152016.
Artículo
en Inglés
| MEDLINE | ID: mdl-27030402
5.
Inhibition of stress-induced hepatic tryptophan 2,3-dioxygenase exhibits antidepressant activity in an animal model of depressive behaviour.
Int J Neuropsychopharmacol
; 17(6): 917-28, 2014 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-24472498
6.
[18F]MPPF and [18F]FDG µPET imaging in rats: impact of transport and restraint stress.
EJNMMI Res
; 10(1): 112, 2020 Sep 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-32990819
7.
Systematic review of guidelines for internal validity in the design, conduct and analysis of preclinical biomedical experiments involving laboratory animals.
BMJ Open Sci
; 4(1): e100046, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-35047688
8.
Longitudinal Characterization of [18F]-FDG and [18F]-AV45 Uptake in the Double Transgenic TASTPM Mouse Model.
J Alzheimers Dis
; 55(4): 1537-1548, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-27911309
9.
Evaluation of Small-Animal PET Outcome Measures to Detect Disease Modification Induced by BACE Inhibition in a Transgenic Mouse Model of Alzheimer Disease.
J Nucl Med
; 58(12): 1977-1983, 2017 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-28611242
10.
Synthesis and Evaluation of a Zr-89-Labeled Monoclonal Antibody for Immuno-PET Imaging of Amyloid-ß Deposition in the Brain.
Mol Imaging Biol
; 18(4): 598-605, 2016 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-26846128
11.
In Vivo Amyloid-ß Imaging in the APPPS1-21 Transgenic Mouse Model with a (89)Zr-Labeled Monoclonal Antibody.
Front Aging Neurosci
; 8: 67, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-27064204
12.
In vivo molecular neuroimaging of glucose utilization and its association with fibrillar amyloid-ß load in aged APPPS1-21 mice.
Alzheimers Res Ther
; 7(1): 76, 2015 Dec 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-26666747
13.
Quantitative µPET Imaging of Cerebral Glucose Metabolism and Amyloidosis in the TASTPM Double Transgenic Mouse Model of Alzheimer's Disease.
Curr Alzheimer Res
; 12(7): 694-703, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-26159204
14.
Preclinical Comparison of the Amyloid-ß Radioligands [(11)C]Pittsburgh compound B and [(18)F]florbetaben in Aged APPPS1-21 and BRI1-42 Mouse Models of Cerebral Amyloidosis.
Mol Imaging Biol
; 17(5): 688-96, 2015 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-25701131
15.
In vivo evaluation of (18)F-labeled TCO for pre-targeted PET imaging in the brain.
Nucl Med Biol
; 41(6): 513-23, 2014 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-24768149
16.
Erratum to: Preclinical Comparison of the Amyloid-ß Radioligands [(11)C]Pittsburgh compound B and [(18)F]florbetaben in Aged APPPS1-21 and BRI1-42 Mouse Models of Cerebral Amyloidosis.
Mol Imaging Biol
; 17(6): 893, 2015 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-26514356
Resultados
1 -
16
de 16
1
Próxima >
>>